Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.39465 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.36329 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.36646 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.33087 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.33915 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.42267 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.36052 | 13 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.34521 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.33211 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.34953 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.34577 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.32975 | 14 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.36199 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.35195 | 15 |